期刊
HUMAN MOLECULAR GENETICS
卷 18, 期 17, 页码 3244-3256出版社
OXFORD UNIV PRESS
DOI: 10.1093/hmg/ddp262
关键词
-
资金
- 'Instituut voor de Aanmoediging van Innovatie door Wetenschap en Technologie Vlaanderen' (IWT) [SB53523]
- 'Fonds voor Wetenschappelijk Onderzoek Vlaanderen' (FWO) [G. 0504.06, G. 0553.08]
- Marie Curie European Reintegration
- 'Vlaams Instituut voor Biotechnologie' (VIB)
- 'Katholieke Universiteit Leuven'
- European Union [LSHM-2005512131]
- 'Fonds voor Wetenschappelijk Onderzoek Vlaanderen' ( FWO) [G. 0504.06]
The conserved oligomeric Golgi (COG) complex is a hetero-octameric complex essential for normal glycosylation and intra-Golgi transport. An increasing number of congenital disorder of glycosylation type II (CDG-II) mutations are found in COG subunits indicating its importance in glycosylation. We report a new CDG-II patient harbouring a p.R729W missense mutation in COG4 combined with a submicroscopical deletion. The resulting downregulation of COG4 expression additionally affects expression or stability of other lobe A subunits. Despite this, full complex formation was maintained albeit to a lower extent as shown by glycerol gradient centrifugation. Moreover, our data indicate that subunits are present in a cytosolic pool and full complex formation assists tethering preceding membrane fusion. By extending this study to four other known COG-deficient patients, we now present the first comparative analysis on defects in transport, glycosylation and Golgi ultrastructure in these patients. The observed structural and biochemical abnormalities correlate with the severity of the mutation, with the COG4 mutant being the mildest. All together our results indicate that intact COG complexes are required to maintain Golgi dynamics and its associated functions. According to the current CDG nomenclature, this newly identified deficiency is designated CDG-IIj.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据